Total Payments
$5,525
2024 Payments
$3,955
Companies
19
Transactions
115
Medicare Patients
344
Medicare Billing
$49,564
Payment Breakdown by Category
Consulting$2,800 (50.7%)
Food & Beverage$1,776 (32.1%)
Travel$900.35 (16.3%)
Education$49.10 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,800 | 1 | 50.7% |
| Food and Beverage | $1,776 | 105 | 32.1% |
| Travel and Lodging | $900.35 | 4 | 16.3% |
| Education | $49.10 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,288 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $279.72 | 20 | $0 (2023) |
| INSYS Therapeutics Inc | $193.60 | 14 | $0 (2018) |
| Novo Nordisk Inc | $169.27 | 10 | $0 (2020) |
| Lilly USA, LLC | $112.65 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $91.97 | 7 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $63.14 | 4 | $0 (2021) |
| PFIZER INC. | $62.07 | 4 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $41.29 | 2 | $0 (2020) |
| Dexcom, Inc. | $36.33 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,955 | 9 | Amgen Inc. ($3,955) |
| 2023 | $32.69 | 2 | Lilly USA, LLC ($17.74) |
| 2022 | $36.33 | 2 | Dexcom, Inc. ($36.33) |
| 2021 | $67.68 | 5 | Lilly USA, LLC ($30.03) |
| 2020 | $202.50 | 12 | Novo Nordisk Inc ($63.71) |
| 2019 | $187.82 | 13 | Amgen Inc. ($65.52) |
| 2018 | $418.51 | 27 | Amgen Inc. ($118.94) |
| 2017 | $624.93 | 45 | Janssen Pharmaceuticals, Inc ($176.02) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Travel and Lodging | In-kind items and services | $366.34 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Travel and Lodging | In-kind items and services | $238.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Travel and Lodging | In-kind items and services | $175.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Travel and Lodging | In-kind items and services | $120.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $48.89 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $144.03 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 12/09/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Endocrinology | ||||||
| 08/30/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Endocrinology | ||||||
| 12/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Gastroenterology | ||||||
| 06/04/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 05/14/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 05/04/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.61 | General |
| Category: Cardiovascular | ||||||
| 11/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 09/25/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: ANTIBIOTIC | ||||||
| 09/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 09/03/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2020 | Philips Electronics North America Corporation | (7999) SRC Undivided (Device) | Food and Beverage | Cash or cash equivalent | $30.47 | General |
| Category: Devices | ||||||
| 08/25/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 08/21/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 18 | $2,396 | $476.85 |
| 2022 | 3 | 59 | 143 | $21,324 | $7,746 |
| 2021 | 6 | 143 | 332 | $56,071 | $21,974 |
| 2020 | 6 | 127 | 308 | $52,680 | $19,368 |
Total Patients
344
Total Services
801
Medicare Billing
$49,564
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 18 | $2,396 | $476.85 | 19.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 57 | $8,322 | $3,101 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 54 | $6,858 | $2,504 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 32 | $6,144 | $2,140 | 34.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 143 | $20,878 | $8,062 | 38.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 33 | 83 | $10,541 | $4,109 | 39.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 24 | $9,000 | $3,659 | 40.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 52 | $9,984 | $3,504 | 35.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 11 | 11 | $3,179 | $1,570 | 49.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 19 | $2,489 | $1,070 | 43.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 141 | $20,586 | $8,092 | 39.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 21 | $7,875 | $3,286 | 41.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 27 | 48 | $9,216 | $2,669 | 29.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 23 | 62 | $7,874 | $2,292 | 29.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 19 | $4,902 | $2,051 | 41.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 12 | 17 | $2,227 | $978.67 | 43.9% |
About Dr. Keyvan Ravakhah, M.D
Dr. Keyvan Ravakhah, M.D is a Specialist healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346298569.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keyvan Ravakhah, M.D has received a total of $5,525 in payments from pharmaceutical and medical device companies, with $3,955 received in 2024. These payments were reported across 115 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($2,800).
As a Medicare-enrolled provider, Ravakhah has provided services to 344 Medicare beneficiaries, totaling 801 services with total Medicare billing of $49,564. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Cleveland, OH
- Active Since 05/04/2006
- Last Updated 02/03/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1346298569
Products in Payments
- KRYSTEXXA (Biological) $3,955
- XARELTO (Drug) $186.59
- Prolia (Biological) $165.77
- ELIQUIS (Drug) $154.04
- SUBSYS (Drug) $107.31
- Ozempic (Drug) $89.63
- SYNDROS (Drug) $86.29
- INVOKANA (Drug) $78.30
- TRULICITY (Drug) $65.78
- Aimovig (Biological) $64.69
- XIFAXAN (Drug) $63.14
- Repatha (Biological) $55.57
- Tresiba (Drug) $49.78
- NUZYRA (Drug) $41.29
- EVENITY (Biological) $40.48
- Dexcom G6 Transmitter (Medical Supply) $36.33
- LifeVest (Device) $30.94
- (7999) SRC Undivided (Device) $30.47
- Victoza (Drug) $29.86
- HUMALOG (Drug) $29.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Cleveland
Dr. Viktor Krebs, M.d, M.D
Specialist — Payments: $7.4M
Specialist $7.4M
Dr. Marc Abrams, M.d., Ph.d, M.D., PH.D
Specialist — Payments: $208,388
Specialist $208,388
Dr. Rabi Hanna, M.d, M.D
Specialist — Payments: $122,916
Specialist $122,916
Dr. Kenneth Mccurry, Md, MD
Specialist — Payments: $69,377
Specialist $69,377
Dr. Claudio Fiocchi, M.d, M.D
Specialist — Payments: $56,102
Specialist $56,102
Dr. Roger Blake, M.d, M.D
Specialist — Payments: $15,981
Specialist $15,981